Nu-Med Plus (NUMD) Other Non Operating Income (2015 - 2021)
Nu-Med Plus' (NUMD) quarterly Other Non Operating Income came in at $9384.0 in Q2 2021, up 100.14% quarter-over-quarter from -$6.7 million in Q4 2017.
Powered by 
Analysis
Nu-Med Plus (NUMD) Other Non Operating Income (2015 - 2021) Analysis & Trends
Nu-Med Plus has disclosed Other Non Operating Income across 4 years of filings, most recently posting $9384.0 for Q2 2021.
- In Q2 2021, Other Non Operating Income changed N/A year-over-year to $9384.0; the TTM figure through Dec 2021 stood at $9384.0 (changed N/A YoY), while the FY2022 annual figure was $50000.0, up 432.82% from the prior year.
- Other Non Operating Income came in at $9384.0 for Q2 2021 at Nu-Med Plus, up from -$6.7 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $9384.0 in Q2 2021 to a low of -$6.7 million in Q1 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | 9,384.00 |
| Dec 31, 2017 | -6.72 Mn |
| Mar 31, 2017 | -6.72 Mn |
| Dec 31, 2016 | 10.94 Mn |
| Mar 31, 2016 | 11.05 Mn |
| Dec 31, 2015 | -7.92 Mn |